Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase

Butler, Kyle V.; Ma, Anqi; Yu, Wenyu; Li, Fengling; Tempel, Wolfram; Babault, Nicolas; Pittella-Silva, Fabio; Shao, Jason; Wang, Junyi; Luo, Minkui; Vedadi, Masoud; Brown, Peter J.; Arrowsmith, Cheryl H.; Jin, Jian

doi:10.1021/acs.jmedchem.6b01244

Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase

Journal Article · Wed Nov 02 00:00:00 EDT 2016 · Journal of Medicinal Chemistry

DOI:https://doi.org/10.1021/acs.jmedchem.6b01244· OSTI ID:1352275

Butler, Kyle V. ^[1]; Ma, Anqi ^[1]; Yu, Wenyu ^[2]; Li, Fengling ^[2]; Tempel, Wolfram ^[2]; Babault, Nicolas ^[1]; Pittella-Silva, Fabio ^[3]; Shao, Jason ^[1]; Wang, Junyi ^[3]; Luo, Minkui ^[3]; Vedadi, Masoud ^[2]; Brown, Peter J. ^[2]; Arrowsmith, Cheryl H. ^[2]; Jin, Jian ^[1]

Icahn School of Medicine at Mount Sinai, New York, NY (United States)
Univ. of Toronto, ON (Canada)
Memorial Sloan Kettering Cancer Center, New York, NY (United States)

Selective inhibitors of protein lysine methyltransferases, including SET domain-containing protein 8 (SETD8), are highly desired, as only a fraction of these enzymes are associated with high-quality inhibitors. From our previously discovered SETD8 inhibitor, we developed a more potent analog and solved a cocrystal structure, which is the first crystal structure of SETD8 in complex with a small-molecule inhibitor. This cocrystal structure allowed the design of a covalent inhibitor of SETD8 (MS453), which specifically modifies a cysteine residue near the inhibitor binding site, has an IC₅₀ value of 804 nM, reacts with SETD8 with near-quantitative yield, and is selective for SETD8 against 28 other methyltransferases. We also solved the crystal structure of the covalent inhibitor in complex with SETD8. In conclusiont, this work provides atomic-level perspective on the inhibition of SETD8 by small molecules and will help identify high-quality chemical probes of SETD8.

View Accepted Manuscript (DOE)

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: AbbVie; American Cancer Society; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative; Janssen; Merck & Co.; National Institutes of Health (NIH); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; São Paulo Research Foundation (FAPESP); Takeda; USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23); Wellcome Trust

Grant/Contract Number:: AC02-06CH11357

OSTI ID:: 1352275

Journal Information:: Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 21 Vol. 59; ISSN 0022-2623

Publisher:: American Chemical Society (ACS)Copyright Statement

Country of Publication:: United States

Language:: ENGLISH

References (52)

Developing Irreversible Inhibitors of the Protein Kinase Cysteinome Liu, Qingsong; Sabnis, Yogesh; Zhao, Zheng Chemistry & Biology, Vol. 20, Issue 2 https://doi.org/10.1016/j.chembiol.2012.12.006	journal	February 2013
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase Kubicek, Stefan; O'Sullivan, Roderick J.; August, E. Michael Molecular Cell, Vol. 25, Issue 3 https://doi.org/10.1016/j.molcel.2007.01.017	journal	February 2007
Modulation of p53 Function by SET8-Mediated Methylation at Lysine 382 Shi, Xiaobing; Kachirskaia, Ioulia; Yamaguchi, Hiroshi Molecular Cell, Vol. 27, Issue 4 https://doi.org/10.1016/j.molcel.2007.07.012	journal	August 2007
Roles of the EZH2 histone methyltransferase in cancer epigenetics Simon, Jeffrey A.; Lange, Carol A. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 647, Issue 1-2 https://doi.org/10.1016/j.mrfmmm.2008.07.010	journal	December 2008
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases Eram, Mohammad S.; Shen, Yudao; Szewczyk, Magdalena M. ACS Chemical Biology, Vol. 11, Issue 3 https://doi.org/10.1021/acschembio.5b00839	journal	December 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K. ACS Medicinal Chemistry Letters, Vol. 6, Issue 5 https://doi.org/10.1021/acsmedchemlett.5b00037	journal	March 2015
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2 Sweis, Ramzi F.; Wang, Zhi; Algire, Mikkel ACS Medicinal Chemistry Letters, Vol. 6, Issue 6 https://doi.org/10.1021/acsmedchemlett.5b00124	journal	May 2015
Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor Mitchell, Lorna H.; Boriack-Sjodin, P. Ann; Smith, Sherri ACS Medicinal Chemistry Letters, Vol. 7, Issue 2 https://doi.org/10.1021/acsmedchemlett.5b00272	journal	August 2015
Structure and Mechanisms of Lysine Methylation Recognition by the Chromodomain in Gene Transcription Yap, Kyoko L.; Zhou, Ming-Ming Biochemistry, Vol. 50, Issue 12 https://doi.org/10.1021/bi101885m	journal	March 2011
Small-Molecule Inhibitors of SETD8 with Cellular Activity Blum, Gil; Ibáñez, Glorymar; Rao, Xiangjun ACS Chemical Biology, Vol. 9, Issue 11 https://doi.org/10.1021/cb500515r	journal	September 2014
Chemical Probes of Histone Lysine Methyltransferases Kaniskan, H. Ümit; Jin, Jian ACS Chemical Biology, Vol. 10, Issue 1 https://doi.org/10.1021/cb500785t	journal	November 2014
Retrieval of Crystallographically-Derived Molecular Geometry Information Bruno, Ian J.; Cole, Jason C.; Kessler, Magnus Journal of Chemical Information and Computer Sciences, Vol. 44, Issue 6 https://doi.org/10.1021/ci049780b	journal	November 2004
Structural Chemistry of the Histone Methyltransferases Cofactor Binding Site Campagna-Slater, Valérie; Mok, Man Wai; Nguyen, Kong T. Journal of Chemical Information and Modeling, Vol. 51, Issue 3 https://doi.org/10.1021/ci100479z	journal	February 2011
Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines. Liu, Feng; Chen, Xin; Allali-Hassani, Abdellah Journal of Medicinal Chemistry, Vol. 53, Issue 15 https://doi.org/10.1021/jm100478y	journal	August 2010
Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines Liu, Feng; Barsyte-Lovejoy, Dalia; Allali-Hassani, Abdellah Journal of Medicinal Chemistry, Vol. 54, Issue 17 https://doi.org/10.1021/jm200903z	journal	September 2011
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP Liu, Feng; Barsyte-Lovejoy, Dalia; Li, Fengling Journal of Medicinal Chemistry, Vol. 56, Issue 21 https://doi.org/10.1021/jm401480r	journal	October 2013
Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8 Ma, Anqi; Yu, Wenyu; Li, Fengling Journal of Medicinal Chemistry, Vol. 57, Issue 15 https://doi.org/10.1021/jm500871s	journal	July 2014
Selective Inhibitors of Protein Methyltransferases Kaniskan, H. Ümit; Konze, Kyle D.; Jin, Jian Journal of Medicinal Chemistry, Vol. 58, Issue 4 https://doi.org/10.1021/jm501234a	journal	December 2014
Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors Flanagan, Mark E.; Abramite, Joseph A.; Anderson, Dennis P. Journal of Medicinal Chemistry, Vol. 57, Issue 23 https://doi.org/10.1021/jm501412a	journal	November 2014
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays Baell, Jonathan B.; Holloway, Georgina A. Journal of Medicinal Chemistry, Vol. 53, Issue 7 https://doi.org/10.1021/jm901137j	journal	April 2010
Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a Liu, Feng; Chen, Xin; Allali-Hassani, Abdellah Journal of Medicinal Chemistry, Vol. 52, Issue 24 https://doi.org/10.1021/jm901543m	journal	December 2009
Nahuoic Acid A Produced by a Streptomyces sp. Isolated From a Marine Sediment Is a Selective SAM-Competitive Inhibitor of the Histone Methyltransferase SETD8 Williams, David E.; Dalisay, Doralyn S.; Li, Fengling Organic Letters, Vol. 15, Issue 2 https://doi.org/10.1021/ol303416k	journal	December 2012
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Liu, Feng Nature Chemical Biology, Vol. 7, Issue 8 https://doi.org/10.1038/nchembio.599	journal	July 2011
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin Morin, Ryan D.; Johnson, Nathalie A.; Severson, Tesa M. Nature Genetics, Vol. 42, Issue 2 https://doi.org/10.1038/ng.518	journal	January 2010
Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7 Langer, Gerrit; Cohen, Serge X.; Lamzin, Victor S. Nature Protocols, Vol. 3, Issue 7 https://doi.org/10.1038/nprot.2008.91	journal	June 2008
MLL translocations, histone modifications and leukaemia stem-cell development Krivtsov, Andrei V.; Armstrong, Scott A. Nature Reviews Cancer, Vol. 7, Issue 11 https://doi.org/10.1038/nrc2253	journal	November 2007
Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers Chi, Ping; Allis, C. David; Wang, Gang Greg Nature Reviews Cancer, Vol. 10, Issue 7 https://doi.org/10.1038/nrc2876	journal	July 2010
Critical roles of non-histone protein lysine methylation in human tumorigenesis Hamamoto, Ryuji; Saloura, Vassiliki; Nakamura, Yusuke Nature Reviews Cancer, Vol. 15, Issue 2 https://doi.org/10.1038/nrc3884	journal	January 2015
Protein methyltransferases as a target class for drug discovery Copeland, Robert A.; Solomon, Michael E.; Richon, Victoria M. Nature Reviews Drug Discovery, Vol. 8, Issue 9 https://doi.org/10.1038/nrd2974	journal	September 2009
Epigenetic protein families: a new frontier for drug discovery Arrowsmith, Cheryl H.; Bountra, Chas; Fish, Paul V. Nature Reviews Drug Discovery, Vol. 11, Issue 5 https://doi.org/10.1038/nrd3674	journal	April 2012
Histone methylation: a dynamic mark in health, disease and inheritance Greer, Eric L.; Shi, Yang Nature Reviews Genetics, Vol. 13, Issue 5 https://doi.org/10.1038/nrg3173	journal	April 2012
Structure–activity relationship studies of SETD8 inhibitors Ma, Anqi; Yu, Wenyu; Xiong, Yan MedChemComm, Vol. 5, Issue 12 https://doi.org/10.1039/C4MD00317A	journal	January 2014
Structural origins for the product specificity of SET domain protein methyltransferases Couture, J. -F.; Dirk, L. M. A.; Brunzelle, J. S. Proceedings of the National Academy of Sciences, Vol. 105, Issue 52 https://doi.org/10.1073/pnas.0806712105	journal	December 2008
Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase Couture, J. -F. Genes & Development, Vol. 19, Issue 12 https://doi.org/10.1101/gad.1318405	journal	June 2005
PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription Beck, D. B.; Oda, H.; Shen, S. S. Genes & Development, Vol. 26, Issue 4 https://doi.org/10.1101/gad.177444.111	journal	February 2012
Dynamic regulation of the PR-Set7 histone methyltransferase is required for normal cell cycle progression Wu, S.; Wang, W.; Kong, X. Genes & Development, Vol. 24, Issue 22 https://doi.org/10.1101/gad.1984210	journal	October 2010
A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse Schotta, G.; Sengupta, R.; Kubicek, S. Genes & Development, Vol. 22, Issue 15 https://doi.org/10.1101/gad.476008	journal	August 2008
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
iotbx.cif : a comprehensive CIF toolbox Gildea, Richard J.; Bourhis, Luc J.; Dolomanov, Oleg V. Journal of Applied Crystallography, Vol. 44, Issue 6 https://doi.org/10.1107/S0021889811041161	journal	October 2011
PRODRG : a tool for high-throughput crystallography of protein–ligand complexes Schüttelkopf, Alexander W.; van Aalten, Daan M. F. Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 8 https://doi.org/10.1107/S0907444904011679	journal	July 2004
Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank Yang, Huanwang; Guranovic, Vladimir; Dutta, Shuchismita Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 10 https://doi.org/10.1107/S0907444904019419	journal	September 2004
HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 8 https://doi.org/10.1107/S0907444906019949	journal	July 2006
MolProbity : all-atom structure validation for macromolecular crystallography Chen, Vincent B.; Arendall, W. Bryan; Headd, Jeffrey J. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1 https://doi.org/10.1107/S0907444909042073	journal	December 2009
XDS Kabsch, Wolfgang Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2 https://doi.org/10.1107/S0907444909047337	journal	January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
Overview of the CCP 4 suite and current developments Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D. Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444910045749	journal	March 2011
REFMAC 5 for the refinement of macromolecular crystal structures Murshudov, Garib N.; Skubák, Pavol; Lebedev, Andrey A. Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444911001314	journal	March 2011
How good are my data and what is the resolution? Evans, Philip R.; Murshudov, Garib N. Acta Crystallographica Section D Biological Crystallography, Vol. 69, Issue 7 https://doi.org/10.1107/S0907444913000061	journal	June 2013
wARP : Improvement and Extension of Crystallographic Phases by Weighted Averaging of Multiple-Refined Dummy Atomic Models Perrakis, A.; Sixma, T. K.; Wilson, K. S. Acta Crystallographica Section D Biological Crystallography, Vol. 53, Issue 4 https://doi.org/10.1107/S0907444997005696	journal	July 1997
Histone Lysine Methyltransferase SETD8 Promotes Carcinogenesis by Deregulating PCNA Expression Takawa, Masashi; Cho, Hyun-Soo; Hayami, Shinya Cancer Research, Vol. 72, Issue 13 https://doi.org/10.1158/0008-5472.CAN-11-3701	journal	May 2012
Structural Chemistry of Human SET Domain Protein Methyltransferases Schapira, Matthieu Current Chemical Genomics, Vol. 5, Issue Suppl 1 https://doi.org/10.2174/1875397301005010085	journal	August 2011

Cited By (4)

Inhibitors of Protein Methyltransferases and Demethylases Kaniskan, H. Ümit; Martini, Michael L.; Jin, Jian Chemical Reviews, Vol. 118, Issue 3 https://doi.org/10.1021/acs.chemrev.6b00801	journal	March 2017
Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization Rabal, Obdulia; Castellar, Andrea; Oyarzabal, Julen Journal of Cheminformatics, Vol. 10, Issue 1 https://doi.org/10.1186/s13321-018-0288-5	journal	July 2018
The dynamic conformational landscape of the protein methyltransferase SETD8 Chen, Shi; Wiewiora, Rafal P.; Meng, Fanwang eLife, Vol. 8 https://doi.org/10.7554/elife.45403	journal	May 2019
Quinazolines as inhibitors of chromatin-associated proteins in histones Herrera-Vázquez, Frida S.; Hernández-Luis, Francisco; Medina Franco, José L. Medicinal Chemistry Research, Vol. 28, Issue 4 https://doi.org/10.1007/s00044-019-02300-0	journal	February 2019

Similar Records

Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8

Journal Article · Thu Sep 29 20:00:00 EDT 2016 · ACS Medicinal Chemistry Letters · OSTI ID:1397281

Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase

Journal Article · Mon Feb 13 23:00:00 EST 2017 · Journal of Medicinal Chemistry · OSTI ID:1373766

Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2

Journal Article · Sun May 03 20:00:00 EDT 2015 · ACS Medicinal Chemistry Letters · OSTI ID:1353263

Related Subjects

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
Adducts
Crystal structure
Inhibitors
Monomers
Peptides and proteins

Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase

Citation Formats

References (52)

Cited By (4)

Similar Records

Related Subjects